Skip to content

Automatic Periodic Stimulation and Continuous Electromyography (EMG) for Facial Nerve Monitoring During Parotidectomy

Use of Automatic Periodic Stimulation and Continuous EMG for Facial Nerve Monitoring During Parotidectomy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03172520
Enrollment
10
Registered
2017-06-01
Start date
2017-01-01
Completion date
2017-12-30
Last updated
2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parotid Gland Disorders

Keywords

Parotidectomy

Brief summary

The purpose of this study is to document the safety of the Medtronic automatic periodic stimulating (APS) Electrode Stimulator during a parotidectomy and potentially prevent post-operative facial nerve weakness, which is a relatively common outcome after parotid surgery.

Detailed description

This study will be conducted in two phases. In the first phase the investigators will use the same monitoring system currently used during parotidectomy and requires placement of the APS electrode as the only additional piece of equipment. During this phase, the investigators will record intraoperative EMG data generated by the monitoring system as well as document intra-operative maneuvers that precede adverse EMG events. In the second phase of the study the investigators aim to allow the surgeon to alter his or her techniques, with the information provided by the APS electrode, to reverse adverse EMG changes.

Interventions

DEVICEAPS electrode

The APS electrode is an accessory intended for providing automatic periodic stimulation to nerves when used with the Medtronic Nerve Monitoring Systems.

DEVICEFacial Nerve Monitor

The facial nerve monitoring system records the number of stimulations of the facial nerve during the operation and this data is stored on the device until it is shut down after the surgery is complete.

Sponsors

Medtronic
CollaboratorINDUSTRY
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Parotidectomy: Planned parotid gland surgery (superficial or total parotidectomy) * Benign or malignant disease

Exclusion criteria

* Current pregnancy * Preoperative facial nerve dysfunction * Revision surgery * History of preoperative radiation to the surgical field * Retrograde or extracapsular dissection * Intentional nerve sacrifice (i.e., due to nerve involvement by tumor) * Tumors with proximity to main trunk of facial nerve * Inability to place electrode * Presence of electrode alters surgical technique

Design outcomes

Primary

MeasureTime frameDescription
Change in Electromyography (EMG)baseline, approximately 3 hoursEMG is an electrodiagnostic medicine technique for evaluating and recording the electrical activity produced by skeletal muscles.

Countries

United States

Participant flow

Participants by arm

ArmCount
Facial Nerve Monitoring With APS Electrode
The investigators will use the Facial Nerve Monitor along with the APS electrode during parotidectomy surgery. APS electrode: The APS electrode is an accessory intended for providing automatic periodic stimulation to nerves when used with the Medtronic Nerve Monitoring Systems. Facial Nerve Monitor: The facial nerve monitoring system records the number of stimulations of the facial nerve during the operation and this data is stored on the device until it is shut down after the surgery is complete.
10
Total10

Baseline characteristics

CharacteristicFacial Nerve Monitoring With APS Electrode
Age, Continuous59.67 years
STANDARD_DEVIATION 14.47
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
10 participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
0 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Change in Electromyography (EMG)

EMG is an electrodiagnostic medicine technique for evaluating and recording the electrical activity produced by skeletal muscles.

Time frame: baseline, approximately 3 hours

Population: Study terminated due to limitations in timing and personnel. Data was not collected

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026